Home > Healthcare > Drug Device Combination > Drug Filled Devices > Contraceptives Market

Contraceptives Market Size

  • Report ID: GMI430
  • Published Date: Sep 2024
  • Report Format: PDF

Contraceptives Market Size

Contraceptives Market size was valued at USD 23 billion in 2023 and is expected to exhibit growth at a CAGR of 6.3% from 2024 to 2032. High market growth can be attributed to increasing emphasis on prevention of sexually transmitted diseases, growing awareness about new technologies for pregnancy prevention, and awareness programs for sexual wellness.

 

The market growth is further attributed to the growing awareness of reproductive health and family planning. Governments, NGOs, and healthcare organizations have been actively promoting contraceptive use as part of broader health initiatives aimed at reducing unplanned pregnancies and improving maternal health. Educational campaigns, both in schools and through the media, are helping to spread knowledge about the importance of contraception. This growing awareness is particularly evident in both developed and developing countries, where increased access to information and healthcare services has resulted in higher adoption rates of contraceptives across various demographics.
 

In addition, many countries are implementing policies that provide free or subsidized contraceptives through national healthcare systems, particularly targeting low-income populations. Programs like the Affordable Care Act (ACA) in the U.S., the NHS in the UK, and public health initiatives in countries like India and Brazil have significantly improved access to contraceptive options. Moreover, governments are investing in infrastructure to support family planning education, further facilitating access to a wide range of contraceptive methods, thereby contributing to market growth.
 

Contraceptives refer to a range of medical devices, drugs, and products designed to prevent pregnancy. These products work by inhibiting ovulation, blocking sperm, or creating an unfavorable environment for fertilization. Contraceptive options include oral pills, intrauterine devices (IUDs), condoms, and hormonal patches. They are widely used to control birth rates, support family planning efforts, and provide individuals and couples with greater control over their reproductive health.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global contraceptives industry was valued at USD 23 billion in 2023 and is expected to exhibit a CAGR of 6.3% from 2024 to 2032, attributed to increasing emphasis on prevention of sexually transmitted diseases, and growing awareness about new technologies for pregnancy prevention.

The devices segment generated the highest revenue of USD 16 billion in 2023 as their reliability and ease of use make them appealing to women seeking consistent and low-maintenance birth control.

North America contraceptives market accounted for USD 7.5 billion in 2023 and is anticipated to record a CAGR of 4% between 2024 to 2032, due to rising awareness of family planning and reproductive health, supported by government initiatives and healthcare policies.

Bayer AG, Church & Dwight Co., Inc., Cooper Companies, Evofem Biosciences, HRA Pharma, Maxwellia Ltd, Mayer Laboratories, Inc., and Mithra Pharmaceuticals among others.

Contraceptives Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 16
  • Tables & Figures: 235
  • Countries covered: 23
  • Pages: 110
 Download Free Sample